Ocular Therapeutix (OCUL) PT Lowered to $13 at Cowen
Cowen lowered its price target on Ocular Therapeutix (NASDAQ: OCUL) to $13.00 (from $60.00) while maintaining a Outperform rating ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)